Literature DB >> 15222036

Effect of traditional Chinese medicinal enemas on ulcerative colitis of rats.

Song-Ming Guo1, Hong-Bin Tong, Lian-Song Bai, Wei Yang.   

Abstract

AIM: To investigate the effects of traditional Chinese medicinal enema (TCME) on inflammatory and immune response of colonic mucosa of rats with ulcerative colitis (UC), and to observe the pathogenic mechanism.
METHODS: Thirty UC rats, induced by intestinal enema together with 2.4-dinitrochlorobenzene (DNCB) and acetic acid, were randomly divided into 3 groups, i.e., GI, GII and GIII. Groups GI and GII were administered with TCME and salazosulfapyridine enema (SASPE), respectively. Group GIII was clystered with only normal saline (NSE), served as control. Group GIV was taken from normal rats as reference, once daily, from the 7th day after the establishment of UC for total 28 d. Interleukin-6 (IL-6) in the colonic mucosa was assayed by (3)H-TdR incorporation assay. Colonic mucosal lymphocyte subpopulation adhesive molecules, CD(4)(+)CD(11a )(+), CD(4)(+)CD(18)(+), CD(8)(+)CD(11a)(+), CD(8)(+)CD1(18)(+) (LSAM), tumor necrosis factor (TNF)-alpha, and interferon-gamma (IFN-gamma), were detected by enzyme linked immunosorbent assay (ELISA). Moreover, the expression of TNF-alpha mRNA and IFN-gamma mRNA in colonic mucosa were detected by polymerase chain reaction (RT-PCR).
RESULTS: Before therapies, in model groups, GI, GII and GIII, levels of IL-6, TNF-alpha, IFN-gamma, CD(8)(+)CD(11a)(+) and CD(8)(+)CD(18)(+) were significantly different (38.29+/-2.61 U/mL, 16.54+/-1.23 ng/L, 8.61+/-0.89 ng/L, 13.51+/-2.31% and 12.22+/-1.13%, respectively) compared to those in GIV group (31.56+/-2.47 U/mL, 12.81+/-1.38 ng/L, 5.28+/-0.56 ng/L, 16.68+/-1.41% and 16.79+/-1.11%, respectively). After therapeutic enemas, in GI group, the contents of IL-6 (32.48+/-2.53 U/m), TNF-alpha (13.42+/-1.57 ng/L) and IFN-gamma (5.87+/-0.84 ng/L) were reduced; then, the contents of CD(8)(+)CD(11a)(+) (16.01+/-1.05 %) and CD(8)(+)CD(18)(+) (16.28+/-0.19%) were raised. There was no significant difference between groups GI and GIV, but the difference between groups GI and GII was quite obvious (P<0.05). The expressions of TNF-alpha mRNA and IFN-gamma mRNA in group GIII were much higher than those of group GIV, but those in group GI were significantly suppressed by TCME therapy.
CONCLUSION: Ulcerative colitis is related to colonic regional mucosal inflammatory factors and immune imbalance. TCME can effectively inhibit regional mucosal inflammatory factors and improve their disorder of immunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222036      PMCID: PMC4572230          DOI: 10.3748/wjg.v10.i13.1914

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  44 in total

1.  Preferential Th1 immune response in invariant chain-deficient mice.

Authors:  Ian Topilski; Alon Harmelin; Richard A Flavell; Yoram Levo; Idit Shachar
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

2.  Impaired sensitivity to beta 2 integrin-blocking in ICAM-1-mediated neutrophil migration in ulcerative colitis.

Authors:  B Vainer; J Brimnes; M H Claesson; O H Nielsen
Journal:  Scand J Gastroenterol       Date:  2001-06       Impact factor: 2.423

3.  Increased expression of P-cadherin mRNA in the mouse peritoneum after carbon dioxide insufflation.

Authors:  K Tahara; K Fujii; K Yamaguchi; T Suematsu; N Shiraishi; S Kitano
Journal:  Surg Endosc       Date:  2001-06-12       Impact factor: 4.584

Review 4.  Role of cytokines in the pathogenesis of inflammatory bowel disease.

Authors:  K A Papadakis; S R Targan
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

5.  Evaluation of Th1, Th2 and immunosuppressive cytokine mRNA expression within the colonic mucosa of dogs with idiopathic lymphocytic-plasmacytic colitis.

Authors:  Alison E Ridyard; Timothy J Nuttall; Rod W Else; James W Simpson; Hugh R P Miller
Journal:  Vet Immunol Immunopathol       Date:  2002-07       Impact factor: 2.046

6.  Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper.

Authors:  E Carty; M De Brabander; R M Feakins; D S Rampton
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

7.  Immune activation in the intestinal mucosa before the onset of colitis in Galphai2-deficient mice.

Authors:  L Ohman; L Franzén; U Rudolph; G R Harriman; E Hultgren Hörnquist
Journal:  Scand J Immunol       Date:  2000-07       Impact factor: 3.487

8.  The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis.

Authors:  Ivan J Fuss; Monica Boirivant; Brian Lacy; Warren Strober
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

9.  Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50.

Authors:  F Driessler; K Venstrom; R Sabat; K Asadullah; A J Schottelius
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

10.  Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis.

Authors:  A Fahlgren; S Hammarström; A Danielsson; M-L Hammarström
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

View more
  5 in total

Review 1.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

2.  Effect of Scutellariae Radix extract on experimental dextran-sulfate sodium-induced colitis in rats.

Authors:  Ho-Lam Chung; Grace-Gar-Lee Yue; Ka-Fai To; Ya-Lun Su; Yu Huang; Wing-Hung Ko
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

3.  Uygur medicine Xipayi Kui Jie'an affects gene expression profiles in intestinal tissue lesions in a rat model of ulcerative colitis.

Authors:  Kurexi Yunusi; Jingping Zhang; Li Zhong; Gulinisha Mosha; Ajiguli Nuermaimaiti; Mairipaiti Abudula; Halmurat Upur
Journal:  BMC Complement Altern Med       Date:  2015-05-22       Impact factor: 3.659

Review 4.  Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review.

Authors:  Maciej Sałaga; Hubert Zatorski; Marta Sobczak; Chunqiu Chen; Jakub Fichna
Journal:  Curr Treat Options Oncol       Date:  2014-09

5.  Efficacy and safety of gwakhyangjeonggi-san retention enema in normal rats and spontaneously hypertensive rats.

Authors:  Eunyoung Song; Euiju Lee; Yongmin Bu; Junhee Lee; Seungwon Shin; Junghee Yoo; Jaewoo Park; Jinhyeok Kwon
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-17       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.